Your browser doesn't support javascript.
loading
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers.
Rubinstein, Mark P; Williams, Cameron; Mart, Caroline; Beall, Jonathan; MacPherson, Linda; Azar, Joseph; Swiderska-Syn, Marzena; Manca, Paolo; Gibney, Barry C; Robinson, Mark D; Krieg, Carsten; Hill, Elizabeth G; Taha, Sharif A; Rock, Amy D; Lee, John H; Soon-Shiong, Patrick; Wrangle, John.
Afiliação
  • Rubinstein MP; The Pelotonia Institute for Immuno-Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus, OH.
  • Williams C; Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Mart C; Department of Surgery, Medical University of South Carolina, Charleston, SC.
  • Beall J; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
  • MacPherson L; Department of Surgery, Medical University of South Carolina, Charleston, SC.
  • Azar J; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
  • Swiderska-Syn M; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC.
  • Manca P; Department of Surgery, Medical University of South Carolina, Charleston, SC.
  • Gibney BC; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
  • Robinson MD; The Pelotonia Institute for Immuno-Oncology, The Ohio State University James Comprehensive Cancer Center, Columbus, OH.
  • Krieg C; Department of Internal Medicine, The Ohio State University, Columbus, OH.
  • Hill EG; Department of Surgery, Medical University of South Carolina, Charleston, SC.
  • Taha SA; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
  • Rock AD; Department of Medical Oncology, IRCCS Foundation - National Cancer Institute, Milan, Italy.
  • Lee JH; Department of Surgery, Medical University of South Carolina, Charleston, SC.
  • Soon-Shiong P; Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland.
  • Wrangle J; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC.
J Immunol ; 208(6): 1362-1370, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35228263
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Interleucina-15 Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Interleucina-15 Limite: Humans Idioma: En Revista: J Immunol Ano de publicação: 2022 Tipo de documento: Article